Who Are Most Protected Against The Delta COVID Variant?

The sudden surge of COVID-19 cases in the past and the emergence of new variants time and again indicate the unpredictability of the SARs-COV-2 virus. The B.1.617.2 variant of coronavirus, also known as the Delta variant has been categorized as a Variant of Concern (VoC) and is said to have driven India’s second wave. While the country returns back to a state of normalcy, scientists and medical professionals continue to look into the many layers of COVID variants in order to gear up for a potential third wave.

The Delta variant carries the genetic code from two other mutations, E484Q and L452R, which is why it becomes all the more easy for it to break into the human immune system and invade the organs. Additionally, as the new variants tend to alter the structure of the spike protein, it is more efficient in attaching itself to the human host cells and multiplies swiftly, doing more damage than an originally COVID strain. While non-vaccinated/partially vaccinated individuals and people with pre-existing comorbidities are at a greater risk of developing the Delta variant, a recent study reveals the list of people who may be protected from the variant of concern.

According to the study conducted by the researchers from the Indian Council of Medical Research, National Institute of Virology, Department of Neurosurgery, Command Hospital (Southern Command), Armed Forces Medical College, Pune, recovered COVID patients who have either received one or both their COVID shots (Covishield) have maximum protection against the Delta variant of coronavirus.

The study took into account immune responses of 5 categories of people.

  1. One dose vaccinated

  2. Two doses vaccinated,

  3. COVID-19 recovered plus one dose vaccinated

  4. COVID-19 recovered plus two doses vaccinated

  5. Breakthrough COVID-19 cases

As per the study, breakthrough cases and recovered COVID-19 patients who have either received one or two doses of vaccine have relatively higher protection against Delta variant as compared to those who have never been infected and are fully vaccinated

As per the ICMR study, “The worldwide endeavour of scientists to create a safe and effective COVID19 vaccine has resulted in the availability of 18 vaccines, which have received Emergency Use Authorization. The vaccines available against SARS-CoV-2, have shown efficacy ranging from 51 % to 94% against the original strain D614G in phase 3 clinical trials. Immune response to SARS-CoV-2 infection involves innate immune activation and antigen-specific responses of B and T cells. Particularly, the questions about the immune escape of, newly emerging VOCs in vaccinated individuals are still being explored. For example, the efficacy of AZD1222, which was reported to be 70% in the UK and Brazil, only reached 22% in South Africa.”

Ref Link: https://www.aarp.org/health/conditions-treatments/info-2021/delta-coronavirus-variant.html



All About COVID-19 For Your Patients

WhiteCoats Insights For Your Practice

Join Thousands of Doctors who Trust WhiteCoats as their Professional Success Partner

For more queries, Call +91-7406-485-000 or mail us at sales@whitecoats.com

Download our App